explore -WSS

explore

author：fashion 2025-09-05 09:18:19 - browse：28

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Liver decline slowed by off

Wikipedia

WSS

Schizophrenia gene found to be linked to cells' energy dysfunction

Aspartame and sugar

Scrutiny of post

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Illumina slashes 2023 revenue projections yet again

For longer

focus

explore

entertainment

How one medical school became remarkably diverse

Treatments for cramps don't cut it. Why aren't there better options?

Apple is now the first public company to be valued at $3 trillion

Patients, digital health players weigh in on FTC's data privacy plan

New air purifier tech could be key to improving indoor air quality

Bird flu researchers hone in on Finland’s mink farms

New air purifier tech could be key to improving indoor air quality

Surge in Apellis stock fueled by confidence in safety of its eye drug

Continuity nursing helped my family in our darkest PICU moments

Liver decline slowed by off

explore

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Biogen joins immunology wave with $1.15 billion acquisition of HI

Eyeing GLP

Aspartame and sugar

Timeline: How the deadly wildfires took over Maui day by day

Maui wildfire now ranks as the fifth

leisure time

entertainment

Wikipedia

knowledge